IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled
- PMID: 10851052
- DOI: 10.1038/sj.onc.1203594
IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled
Abstract
Hematopoiesis is the cumulative result of intricately regulated signal transduction cascades that are mediated by cytokines and their cognate receptors. Proper culmination of these diverse signaling pathways forms the basis for an orderly generation of different cell types and aberrations in these pathways is an underlying cause for diseases such as cancer. Over the past several years, downstream events initiated upon cytokine/growth factor stimulation have been a major focus of biomedical research. As a result, several key concepts have emerged allowing a better understanding of the complex signaling processes. A group of novel transcription factors, termed signal transducers and activators of transcription (STATs) appear to orchestrate the downstream events propagated by cytokine/growth factor interactions with their cognate receptors. Until recently, the JAK proteins were considered to be the tyrosine kinases, which dictated the levels of phosphorylation and activation of STAT proteins, forming the basis of the JAK-STAT model. However, over the past few years, increasing evidence has accumulated which indicates that at least some of the STAT protein activation may be mediated by members of the Src gene family following cytokine/growth factor stimulation. Studies have demonstrated that the Src-family of tyrosine kinases can phosphorylate and activate certain STAT proteins, in lieu of JAK kinases. In such a scenario, JAK kinases may be more crucial to phosphorylation of the cytokine/growth factor receptors and in the process create docking sites on the receptors for binding of SH2-containing proteins such as STATs, Src-kinases and other signaling intermediates. Tyrosine phosphorylation and activation of STAT proteins can be achieved either by JAKs or Src-kinases depending on the nature of STAT that is being activated. This forms the basis for the JAK-Src-STAT model proposed in this review. The concerted action of JAK kinases, members of the Src-kinase family and STAT proteins, leads to cell proliferation and cell survival, the end-point of the cytokine/growth factor stimulus. Oncogene (2000).
Similar articles
-
JAKs, STATs and Src kinases in hematopoiesis.Oncogene. 2002 May 13;21(21):3334-58. doi: 10.1038/sj.onc.1205398. Oncogene. 2002. PMID: 12032773 Review.
-
Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.Oncogene. 1998 Apr 2;16(13):1749-58. doi: 10.1038/sj.onc.1201972. Oncogene. 1998. PMID: 9582023
-
The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.Oncogene. 2000 Sep 28;19(41):4795-801. doi: 10.1038/sj.onc.1203829. Oncogene. 2000. PMID: 11032030
-
Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):759-66. Biochem J. 2000. PMID: 10642538 Free PMC article.
-
The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):75-120. doi: 10.3109/10799899909036638. J Recept Signal Transduct Res. 1999. PMID: 10071751 Review.
Cited by
-
Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells.Mol Oncol. 2012 Oct;6(5):484-93. doi: 10.1016/j.molonc.2012.05.002. Epub 2012 Jun 2. Mol Oncol. 2012. PMID: 22717603 Free PMC article.
-
14-3-3:Shc scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate phosphatidylinositol 3-kinase activation and cell survival.J Biol Chem. 2009 May 1;284(18):12080-90. doi: 10.1074/jbc.M807637200. Epub 2009 Feb 13. J Biol Chem. 2009. PMID: 19218246 Free PMC article.
-
Developmental and Functional Control of Natural Killer Cells by Cytokines.Front Immunol. 2017 Aug 4;8:930. doi: 10.3389/fimmu.2017.00930. eCollection 2017. Front Immunol. 2017. PMID: 28824650 Free PMC article. Review.
-
Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus.PLoS Pathog. 2012;8(6):e1002770. doi: 10.1371/journal.ppat.1002770. Epub 2012 Jun 14. PLoS Pathog. 2012. PMID: 22719258 Free PMC article.
-
Salivary chemokines and growth factors in patients with ischemic stroke.Sci Rep. 2025 Apr 12;15(1):12676. doi: 10.1038/s41598-025-97974-5. Sci Rep. 2025. PMID: 40221607 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous